While being downregulated in early stage malignancies and thereby mediating growth promoting effects, upregulation of Caveolin-1 in late stage disease might promote resistance against chemotherapeutic agents in colon cancer as well as metastatic properties in prostate cancer [30]. Here, CAV1 is linked to Familial prostate cancer.